Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
OLAPARIB | A218044 | NATCO PHARMA LIMITED
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED 11 patentsANDA 218044olaparib | D.N.J. | 2025-01-09 | Terminated 2025-06-06 | — |
ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al 8 patentsANDA 218044olaparib | D.N.J. | 2024-05-07 | Active | — |
| D.N.J. | 2023-02-10 | Terminated 2024-07-12 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.